Form D · Other
EXMceuticals Inc.
Calgary, A0 · CIK 0001774782
Offering snapshot reported Aug 31, 2020 · SEC filing
- Reported sold
- $30.5K Offering amount: $30.5K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 20, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2020 | Initial | $30,467 | No comparison | 1 | SEC filing |
| Aug 19, 2020 | Initial | $100,702 | No comparison | 1 | SEC filing |
| Jul 30, 2020 | Initial | $372,550 | No comparison | 1 | SEC filing |
| Apr 26, 2019 | Initial | $329,106 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-374507
Source: Form D, filed Aug 31, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tanek Amin | Executive |
| John Anderson | Director, Executive |
| Marc Bernier | Director |
| Morten Borch | Director |
| Bobby Doyon | Director |
| Genevieve Gagne | Executive |
| Christopher Gulka | Director, Executive |
| Michael Kinley | Director, Executive |
| Julie Lemieux | Executive |
| Michel Passebon | Director, Executive |
| Jonathan Summers | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
421 7th Avenue Sw, 30th Floor
Calgary, A0, T2P 4K9
Calgary, A0, T2P 4K9